Vous êtes ici : Accueil > Archives > Eq. BioMet > Chélateurs spécifiques du cuiv ... > Publications

Publications

Publié le 23 janvier 2019
Chevallet M, Veronesi G, Fuchs A, Mintz E, Michaud-Soret I and Deniaud A
Impact of labile metal nanoparticles on cellular homeostasis. Current developments in imaging, synthesis and applications.
Biochimica et Biophysica Acta - General Subjects, 2017, 1861(6): 1566-1577

Chevallet M, Gallet B, Fuchs A, Jouneau PH, Um K, Mintz E and Michaud-Soret I
Metal homeostasis disruption and mitochondrial dysfunction in hepatocytes exposed to sub-toxic doses of zinc oxide nanoparticles.
Nanoscale, 2016, 8(43): 18495-18506

Hilario-Souza E, Cuillel M, Mintz E, Charbonnier P, Vieyra A, Cassio D and Lowe J
Modulation of hepatic copper-ATPase activity by insulin and glucagon involves protein kinase A (PKA) signaling pathway.
Biochimica Et Biophysica Acta-Molecular Basis of Disease, 2016, 1862(11): 2086-2097

Veronesi G, Deniaud A, Gallon T, Jouneau PH, Villanova J, Delangle P, Carrière M, Kieffer I, Charbonnier P, Mintz E and Michaud-Soret I
Visualization, quantification and coordination of Ag+ ions released from silver nanoparticles in hepatocytes.
Nanoscale, 2016, 8(38): 17012-17021

Monestier M, Charbonnier P, Gateau C, Cuillel M, Robert F, Lebrun C, Mintz E, Renaudet O and Delangle P
ASGPR-mediated uptake of multivalent glycoconjugates for drug delivery in hepatocytes.
Chembiochem, 2016, 17(7): 590-594

Veronesi G, Gallon T, Deniaud A, Boff B, Gateau C, Lebrun C, Vidaud C, Rollin-Genetet F, Carrière M, Kieffer I, Mintz E, Delangle P and Michaud-Soret I
XAS investigation of silver(I) coordination in copper(I) biological binding sites
Inorganic Chemistry, 2015, 54(24): 11688-11696

Gateau C, Mintz E and Delangle P
Rational design of copper and iron chelators to treat Wilson’s Disease and hemochromatosis. In Ligand design in medicinal inorganic chemistry. Edited by Tim Storr. John Wiley & Sons, Ltd, Chichester, 2014, Chap. 11, pp 287-319

Neyrolles O, Mintz E and Catty P
Zinc and copper toxicity in host defense against pathogens: Mycobacterium tuberculosis as a model example of an emerging paradigm.
Frontiers in Cellular and Infection Microbiology, 2013, 3: art. 89

Pujol AM, Cuillel M, Jullien AS, Lebrun C, Cassio D, Mintz E, Gateau C and Delangle P
A sulfur tripod glycoconjugate that releases a high-affinity copper chelator in hepatocytes.
Angewandte Chemie International Edition, 2012, 51(30): 7445-7448

Delangle P and Mintz E
Chelation therapy in Wilson's disease: From D-Penicillamine to the design of selective bioinspired intracellular Cu(I) chelators.
Dalton Transactions, 2012, 41(21): 6359-6370

Pujol AM, Cuillel M, Renaudet O, Lebrun C, Charbonnier P, Cassio D, Gateau C, Dumy P, Mintz E and Delangle P
Hepatocyte targeting and intracellular copper chelation by a thiol-containing glycocyclopeptid.
Journal of the American Chemical Society, 2011, 133(2): 286-296

Frelon S, Carriere M, Floriani M, Delangle P and Mintz E
Comportement des espèces chimiques dans la biosphère : spéciation, biodisponibilité, transferts. Spéciation et Biodisponibilité, "Spéciation et chélation dans le vivant" in Toxicologie Nucléaire Environnementale et Humaine, 2009, Lavoisier pp 27-46